A Confirmatory Trial of Multidisciplinary Digital Therapeutics for Patellofemoral Pain Syndrome

NAActive, not recruitingINTERVENTIONAL
Enrollment

216

Participants

Timeline

Start Date

April 26, 2024

Primary Completion Date

March 31, 2025

Study Completion Date

March 31, 2025

Conditions
Patellofemoral Pain Syndrome
Interventions
DEVICE

MORA Cure

MORA Cure (ETH-01K), developed by EverEx, Inc., is a digital therapeutics (S/W medical device) designed to provide multidisciplinary rehabilitation treatment, a combination of graded exercise therapy and cognitive behavioural therapy for patients with patellofemoral pain syndrome.

OTHER

Treatment as Usual

In the control group, education is delivered and self-exercise is recommended.

Trial Locations (10)

10475

Myongji Hospital, Goyang-si

11923

Hanyang University Guri Hospital, Guri-si

13496

CHA Bundang Medical Center, Seongnam-si

13620

Seoul National University Bundang Hospital, Gyeonggi-do

22332

Inha University Hospital, Junggu

06973

Chung-Ang University Hospital, Dongjak

07061

Seoul Metropolitan Government-Seoul National University Boramae Medical Center, Dongjak

05278

Kyung Hee University Hospital at Gangdong, Gangdong

06591

The Catholic University of Korea Seoul St. Mary's Hospital, Seocho

05505

Asan Medical Center, Seoul

All Listed Sponsors
lead

EverEx Inc.

INDUSTRY

NCT06260865 - A Confirmatory Trial of Multidisciplinary Digital Therapeutics for Patellofemoral Pain Syndrome | Biotech Hunter | Biotech Hunter